Which Drugs Do €' And Don€™t €' Increase Fall Risks for the Elderly Among the underappreciated risks of growing old is the damage a seemingly simple fall can wreak.Falls are the leading cause of injury deaths for people 65 and older, and theyre the most frequent reason for trauma admissions among the...
Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scient MOUNTAIN VIEW, Calif., June 23 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc.(Nasdaq: ALXA) announced today that it will present results of its Phase 2a clinical trial of Staccato(R) loxapine (AZ-104) for the treatment of migraine...
Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scient MOUNTAIN VIEW, Calif., June 23 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc.(Nasdaq: ALXA) announced today that it will present results of its Phase 2a clinical trial of Staccato(R) loxapine (AZ-104) for the treatment of migraine...
Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scient MOUNTAIN VIEW, Calif., June 23 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc.(Nasdaq: ALXA) announced today that it will present results of its Phase 2a clinical trial of Staccato(R) loxapine (AZ-104) for the treatment of migraine...
Roxane Laboratories, Inc Announces the Launch of Ramipril Capsules 6/19/2008 7:38:16 AM More...Roxane Laboratories, Inc.Announces the Launch of Zaleplon Capsules CIV 6/9/2008 7:45:43 AM More...
Roxane Laboratories, Inc.Announces the Launch of Acarbose...
Unichem receives US FDA nod for Zaleplon Unichem Laboratories Ltd, a Mumbai based mid-sized pharmaceutical company, has received the final approval from US Food and Drug Administration (FDA) for Zaleplon capsules in the strengths of 5 mg and 10 mg.Zaleplon is...
Mylan gets US FDA approval for Zaleplon capsules Mylan Inc, announced that its subsidiary, Genpharm ULC, has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Zaleplon capsules, 5 mg and 10 mg.Zaleplon ...
Aurobindo gets US FDA approval for Zaleplon caps Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (US FDA) to manufacture and market Zaleplon capsules 5mg and 10mg.Zaleplon capsules are the generic equivalent of King Pharmaceutical's...
Roxane granted approval for 5mg and 10mg Zaleplon CIV capsules The product is available in bottles of 100 capsules for immediate shipment to wholesalers and pharmacies across the US.Roxane Laboratories's Zaleplon capsules CIV are AB rated to Sonata (zaleplon).
Annual sales of Sonata...
Mylan gets final FDA approval for Zaleplon capsules SAN FRANCISCO (Thomson Financial) - Mylan Inc.said Monday its Genpharm ULC subsidiary has received final approval from the Food and Drug Administration for its Zaleplon capsules in 5 mg and 10 mg strengths.
Zaleplon is the...
Mylan Announces Final FDA Approval for Zaleplon Capsules PITTSBURGH, June 9 /PRNewswire-FirstCall/ -- Mylan Inc.today announced that its subsidiary, Genpharm ULC, has received final approval from the U.S.
Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...
Mylan gets FDA approval to market generic Sonata PITTSBURGH (AP) - Mylan Inc.said Monday the Food and Drug Administration approved the company's application to sell generic capsules of Sonata, an insomnia treatment.
The company will immediately begin shipping Zaleplon capsules...
Teva Introduces Zaleplon Capsules, CIV Zaleplon Capsules, CIV * Sonata is a registered trademark of King Pharmaceuticals.‡ Data on file, Teva USA.
Please see accompanying prescribing information.
NORTH WALES, Pa., June 6, 2008 Teva Pharmaceuticals is...
Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations MOUNTAIN VIEW, Calif., May 29 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc.(Nasdaq: ALXA - News) announced today that Anthony Clarke, PhD, has joined the company as Vice President, International Development Operations.
He will...
Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual MOUNTAIN VIEW, Calif., May 1 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc.(Nasdaq: ALXA - News) announced today that it will present at the 161st American Psychiatric Association annual meeting the results of a Phase 2a clinical...
